Filter
628
Text search:
World
Health
Organization,
Stop
TB
Partnership
Featured
50
174
Language
Document type
443
70
53
27
23
5
5
1
1
Countries / Regions
26
19
18
18
18
16
14
13
13
13
11
10
10
10
10
9
9
8
7
6
6
6
6
6
5
5
5
5
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
227
40
20
10
9
8
2
Toolboxes
265
66
15
14
14
12
9
8
7
6
6
6
5
5
4
3
3
3
2
2
1
1
Lack of Access to Reproductive Healthcare in Sudan’s Rebel-Held Southern Kordofan
Research
Emerging Infectious Diseases Vol. 12, No. 5, May 2006
Epidemiologisches Bulletin; 14. März 2016 Nr. 10/11 ;DOI 10.17886/EpiBull-2016-014
Информационный бюллетень содержит краткое изложение новой стратегии Глобального фонда, опыта, накопленного в ходе первого цикла финансирования на основе выделен
...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf
...
4th edition, Reference Manual
Epidemiologisches Bulletin; 1. Dezember 2014 / Nr. 48
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we
...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
Accessed: 08.10.2019
